SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001424884-12-000026
Filing Date
2012-04-16
Accepted
2012-04-16 16:27:32
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1904635
2 form10-k4.jpg GRAPHIC 17436
3 exhibit31-1.htm EX-31.1 15885
4 exhibit31-2.htm EX-31.2 15169
5 exhibit32-1.htm EX-32.1 5662
6 exhibit32-2.htm EX-32.2 8612
  Complete submission text file 0001424884-12-000026.txt   6384544

Data Files

Seq Description Document Type Size
7 tpiv-20111231.xml EX-101.INS 680663
8 tpiv-20111231.xsd EX-101.SCH 23494
9 tpiv-20111231_cal.xml EX-101.CAL 31734
10 tpiv-20111231_def.xml EX-101.DEF 138688
11 tpiv-20111231_lab.xml EX-101.LAB 188091
12 tpiv-20111231_pre.xml EX-101.PRE 161634
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27239 | Film No.: 12761453
SIC: 2834 Pharmaceutical Preparations